Phase II Study for the Use of Vidaza to Restore Responsiveness of Patients' Prostate Cancers to Hormonal Therapy.

Trial Profile

Phase II Study for the Use of Vidaza to Restore Responsiveness of Patients' Prostate Cancers to Hormonal Therapy.

Completed
Phase of Trial: Phase II

Latest Information Update: 14 Jun 2012

At a glance

  • Drugs Azacitidine (Primary)
  • Indications Prostate cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 14 Jun 2012 Actual patient number is 53 according to ClinicalTrials.gov.
    • 13 Apr 2010 Actual end date (November 2009) added as reported by ClinicalTrials.gov.
    • 13 Apr 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top